Glenmark Life Sciences Limited competitive analysis

Explore patent oppositions filed by Glenmark Life Sciences Limited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Amorphous Lercanidipine HydrochlorideRECORDATI INDUSTRIA CHIMICA E FARMACEUTICANov 13, 2019

Explore Glenmark Life Sciences Limited's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jan 22, 2025Process For Preparation Of Apremilast1

Latest PTAB cases involving Glenmark Life Sciences Limited

Discover the latest PTAB cases involving Glenmark Life Sciences Limited, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Glenmark Life Sciences Limited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLENMARK LIFE SCIENCES LIMITED11 - -
HAMM&WITTKOPP PATENTANWÄLTE PARTMBB81 - - -
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA - 7 - -
RECORDATI IRELAND - 7 - -